Emory Corporate Governance and Accountability Review


Dr. Fadem introduces the increasing problem of unaffordable pharmaceuticals, and addresses that issue by discussing how health care could constructively help patients gain more access to pharmaceuticals. Dr. Fadem accomplishes this goal by discussing the history of the FDA, the process of drug development, the manufacturing of drugs, and the marketing of those drugs. The Article also discusses how stricter regulations in the U.S. than abroad often punish the U.S. patient since the same drug sold overseas can cost double for the U.S. consumer.